Global Disease Control and Prevention Vaccine Professional Survey Report 2023, Forecast to 2028
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period.
Data collected includes market dynamics, technology outlook, application development, and pricing trends. All of this is fed into a research model, which then produces relevant data for market research. Global market trend analysis is given including historical data, estimates to 2023 and compound annual growth rate (CAGR) forecast to 2028.
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
2023 will be a tough year for much of the global economy, as the ongoing war in Ukraine continues to strain trade, especially in Europe, and the global economy remains reeling from the fallout from the COVID-19 pandemic.
But as China moves ever closer to fully reemerging from three years of government-imposed Covid isolation and reintegrating with the world, economic expectations are high.And with the global economy now facing significant challenges, including energy shortages, slowing growth and high inflation, China’s reopening could provide a much-needed and timely boost.
The report researches and analyzes the influence of the Disease Control and Prevention Vaccine industry in the new era of global post-COIVD-19 economy in 2023, and provides in-depth analysis and professional suggestions on the current development.
Market Segment by Product Type
Live-Attenuated
Inactivated
Recombinant Sub Unit and Toxoid
Market Segment by Product Application
Pediatric Vaccine
Adult Vaccine
Finally, the report provides detailed profile and data information analysis of leading company.
GSK
Serum Institute of India Pvt. Ltd
Sanofi
Merck & Co., Inc
Astellas Pharma Inc
Pfizer
Sinovac Biotech Ltd
AstraZeneca PLC
Daiichi Sankyo
Insights and Tools:
We follow a comprehensive process to estimate market size. Key industry dynamics, regulatory scenarios, and segmental dynamics are analyzed to understand their impact on demand over the forecast period. Macroeconomic indicators such as prices, income and demographic changes, demand changes, etc. are considered in estimating market size. We also provide an in-depth profile of the key players and discuss their market shares in the global market to derive the market value. In addition, we have an internal database that is regularly updated with key insights and press releases from key stakeholders in the relevant market.
The data is generally gathered in various arrangements such as charts, graphs, infographics, trends, documents and records from various manufacturers and retailers. Our analyst gather, collect, and interpret such data to form significant databases. Our team then works with large data volumes to analyze core developments, evaluate market estimations, and identify trends.
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
Research Objectives
1.To study and analyze the global Disease Control and Prevention Vaccine consumption (value) by key regions/countries, product type and application, history data from 2018 to 2022, and forecast to 2028.
2.To understand the structure of Disease Control and Prevention Vaccine market by identifying its various subsegments.
3.Focuses on the key global Disease Control and Prevention Vaccine manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Disease Control and Prevention Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Disease Control and Prevention Vaccine submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Global Disease Control and Prevention Vaccine Professional Survey Report Report 2023, Forecast to 2028
1 Market Study Overview
1.1 Study Objectives
1.2 Disease Control and Prevention Vaccine Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Disease Control and Prevention Vaccine Segment by Type
2.1.1 Live-Attenuated
2.1.2 Inactivated
2.1.3 Recombinant Sub Unit and Toxoid
2.2 Market Analysis by Application
2.2.1 Pediatric Vaccine
2.2.2 Adult Vaccine
2.3 Global Disease Control and Prevention Vaccine Market Comparison by Regions (2018-2028)
2.3.1 Global Disease Control and Prevention Vaccine Market Size (2018-2028)
2.3.2 North America Disease Control and Prevention Vaccine Status and Prospect (2018-2028)
2.3.3 Europe Disease Control and Prevention Vaccine Status and Prospect (2018-2028)
2.3.4 Asia-pacific Disease Control and Prevention Vaccine Status and Prospect (2018-2028)
2.3.5 South America Disease Control and Prevention Vaccine Status and Prospect (2018-2028)
2.3.6 Middle East & Africa Disease Control and Prevention Vaccine Status and Prospect (2018-2028)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2020 (Covid-19): Disease Control and Prevention Vaccine Industry Impact
2.5.1 Disease Control and Prevention Vaccine Business Impact Assessment - Covid-19
2.5.2 Market Trends and Disease Control and Prevention Vaccine Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Disease Control and Prevention Vaccine Sales and Market Share by Manufacturer (2018-2023)
3.2 Global Disease Control and Prevention Vaccine Revenue and Market Share by Manufacturer (2018-2023)
3.3 Global Disease Control and Prevention Vaccine Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Disease Control and Prevention Vaccine Manufacturer Market Share
3.5 Top 10 Disease Control and Prevention Vaccine Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Disease Control and Prevention Vaccine Market
3.7 Key Manufacturers Disease Control and Prevention Vaccine Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of Disease Control and Prevention Vaccine Industry Key Manufacturers
4.1 GSK
4.1.1 Company Details
4.1.2 GSK Disease Control and Prevention Vaccine Product Introduction, Application and Specification
4.1.3 GSK Disease Control and Prevention Vaccine Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.1.4 Main Business Overview
4.1.5 GSK News
4.2 Serum Institute of India Pvt. Ltd
4.2.1 Company Details
4.2.2 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product Introduction, Application and Specification
4.2.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.2.4 Main Business Overview
4.2.5 Serum Institute of India Pvt. Ltd News
4.3 Sanofi
4.3.1 Company Details
4.3.2 Sanofi Disease Control and Prevention Vaccine Product Introduction, Application and Specification
4.3.3 Sanofi Disease Control and Prevention Vaccine Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.3.4 Main Business Overview
4.3.5 Sanofi News
4.4 Merck & Co., Inc
4.4.1 Company Details
4.4.2 Merck & Co., Inc Disease Control and Prevention Vaccine Product Introduction, Application and Specification
4.4.3 Merck & Co., Inc Disease Control and Prevention Vaccine Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.4.4 Main Business Overview
4.4.5 Merck & Co., Inc News
4.5 Astellas Pharma Inc
4.5.1 Company Details
4.5.2 Astellas Pharma Inc Disease Control and Prevention Vaccine Product Introduction, Application and Specification
4.5.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.5.4 Main Business Overview
4.5.5 Astellas Pharma Inc News
4.6 Pfizer
4.6.1 Company Details
4.6.2 Pfizer Disease Control and Prevention Vaccine Product Introduction, Application and Specification
4.6.3 Pfizer Disease Control and Prevention Vaccine Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.6.4 Main Business Overview
4.6.5 Pfizer News
4.7 Sinovac Biotech Ltd
4.7.1 Company Details
4.7.2 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product Introduction, Application and Specification
4.7.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.7.4 Main Business Overview
4.7.5 Sinovac Biotech Ltd News
4.8 AstraZeneca PLC
4.8.1 Company Details
4.8.2 AstraZeneca PLC Disease Control and Prevention Vaccine Product Introduction, Application and Specification
4.8.3 AstraZeneca PLC Disease Control and Prevention Vaccine Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.8.4 Main Business Overview
4.8.5 AstraZeneca PLC News
4.9 Daiichi Sankyo
4.9.1 Company Details
4.9.2 Daiichi Sankyo Disease Control and Prevention Vaccine Product Introduction, Application and Specification
4.9.3 Daiichi Sankyo Disease Control and Prevention Vaccine Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.9.4 Main Business Overview
4.9.5 Daiichi Sankyo News
5 Global Disease Control and Prevention Vaccine Sales Categorized by Regions
5.1 Global Disease Control and Prevention Vaccine Revenue, Sales and Market Share by Regions
5.1.1 Global Disease Control and Prevention Vaccine Sales and Market Share by Regions (2018-2023)
5.1.2 Global Disease Control and Prevention Vaccine Revenue and Market Share by Regions (2018-2023)
5.2 North America Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
5.3 Europe Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
5.4 Asia-pacific Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
5.5 South America Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
5.6 Middle East & Africa Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
6 North America Disease Control and Prevention Vaccine Market Size Categorized by Countries
6.1 North America Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Countries
6.1.1 North America Disease Control and Prevention Vaccine Sales (Volume) by Countries (2018-2023)
6.1.2 North America Disease Control and Prevention Vaccine Revenue by Countries (2018-2023)
6.1.3 United States Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
6.1.4 Canada Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
6.1.5 Mexico Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
6.2 North America Disease Control and Prevention Vaccine Revenue (Value) by Manufacturers
6.3 North America Disease Control and Prevention Vaccine Sales and Market Share by Type (2018-2023)
6.4 North America Disease Control and Prevention Vaccine Sales Market Share by Application (2018-2023)
7 Europe Disease Control and Prevention Vaccine Market Size Categorized by Countries
7.1 Europe Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Europe Disease Control and Prevention Vaccine Sales (Volume) by Countries (2018-2023)
7.1.2 Europe Disease Control and Prevention Vaccine Revenue by Countries (2018-2023)
7.1.3 Germany Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
7.1.4 UK Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
7.1.5 France Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
7.1.6 Russia Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
7.1.7 Italy Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
7.1.8 Spain Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
7.2 Europe Disease Control and Prevention Vaccine Revenue (Value) by Manufacturers
7.3 Europe Disease Control and Prevention Vaccine Sales and Market Share by Type (2018-2023)
7.4 Europe Disease Control and Prevention Vaccine Sales Market Share by Application (2018-2023)
8 Asia-Pacific Disease Control and Prevention Vaccine Market Size Categorized by Countries
8.1 Asia-pacific Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Disease Control and Prevention Vaccine Sales (Volume) by Countries (2018-2023)
8.1.2 Asia-pacific Disease Control and Prevention Vaccine Revenue by Countries (2018-2023)
8.1.3 China Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
8.1.4 South Korea Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
8.1.5 Japan Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
8.1.6 Australia Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
8.1.7 India Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
8.1.8 Southeast Asia Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
8.2 Asia-pacific Disease Control and Prevention Vaccine Revenue (Value) by Manufacturers
8.3 Asia-pacific Disease Control and Prevention Vaccine Sales and Market Share by Type (2018-2023)
8.4 Asia-pacific Disease Control and Prevention Vaccine Sales Market Share by Application (2018-2023)
9 South America Disease Control and Prevention Vaccine Market Size Categorized by Countries
9.1 South America Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Countries
9.1.1 South America Disease Control and Prevention Vaccine Sales (Volume) by Countries (2018-2023)
9.1.2 South America Disease Control and Prevention Vaccine Revenue by Countries (2018-2023)
9.1.3 Brazil Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
9.2 South America Disease Control and Prevention Vaccine Sales and Market Share by Type (2018-2023)
9.3 South America Disease Control and Prevention Vaccine Sales Market Share by Application (2018-2023)
10 Middle East and Africa Disease Control and Prevention Vaccine Market Size Categorized by Countries
10.1 Middle East and Africa Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Disease Control and Prevention Vaccine Sales (Volume) by Countries (2018-2023)
10.1.2 Middle East and Africa Disease Control and Prevention Vaccine Revenue by Countries (2018-2023)
10.1.3 GCC Countries Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
10.1.4 Turkey Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
10.1.5 Egypt Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
10.1.6 South America Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
10.2 Middle East and Africa Disease Control and Prevention Vaccine Sales and Market Share by Type
10.3 Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share by Application (2018-2023)
11 Global Disease Control and Prevention Vaccine Market Segment by Type
11.1 Global Disease Control and Prevention Vaccine Revenue, Sales and Market Share by Type (2018-2023)
11.1.1 Global Disease Control and Prevention Vaccine Sales and Market Share by Type (2018-2023)
11.1.2 Global Disease Control and Prevention Vaccine Revenue and Market Share by Type (2018-2023)
11.2 Live-Attenuated Sales Growth Rate and Price
11.2.1 Global Live-Attenuated Sales Growth Rate (2018-2023)
11.2.2 Global Live-Attenuated Price (2018-2023)
11.3 Inactivated Sales Growth Rate and Price
11.3.1 Global Inactivated Sales Growth Rate (2018-2023)
11.3.2 Global Inactivated Price (2018-2023)
11.4 Recombinant Sub Unit and Toxoid Sales Growth Rate and Price
11.4.1 Global Recombinant Sub Unit and Toxoid Sales Growth Rate (2018-2023)
11.4.2 Global Recombinant Sub Unit and Toxoid Price (2018-2023)
12 Global Disease Control and Prevention Vaccine Market Segment by Application
12.1 Global Disease Control and Prevention Vaccine Sales Market Share by Application (2018-2023)
12.2 Pediatric Vaccine Sales Growth Rate (2018-2023)
12.3 Adult Vaccine Sales Growth Rate (2018-2023)
13 Global Disease Control and Prevention Vaccine Market Forecast
13.1 Global Disease Control and Prevention Vaccine Revenue, Sales and Growth Rate (2023-2028)
13.2 Disease Control and Prevention Vaccine Market Forecast by Regions (2023-2028)
13.2.1 North America Disease Control and Prevention Vaccine Market Forecast (2023-2028)
13.2.2 Europe Disease Control and Prevention Vaccine Market Forecast (2023-2028)
13.2.3 Asia-Pacific Disease Control and Prevention Vaccine Market Forecast (2023-2028)
13.2.4 South America Disease Control and Prevention Vaccine Market Forecast (2023-2028)
13.2.5 Middle East & Africa Disease Control and Prevention Vaccine Market Forecast (2023-2028)
13.3 Disease Control and Prevention Vaccine Market Forecast by Type (2023-2028)
13.3.1 Global Disease Control and Prevention Vaccine Sales Forecast by Type (2023-2028)
13.3.2 Global Disease Control and Prevention Vaccine Market Share Forecast by Type (2023-2028)
13.4 Disease Control and Prevention Vaccine Market Forecast by Application (2023-2028)
13.4.1 Global Disease Control and Prevention Vaccine Sales Forecast by Application (2023-2028)
13.4.2 Global Disease Control and Prevention Vaccine Market Share Forecast by Application (2023-2028)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Disease Control and Prevention Vaccine Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Disease Control and Prevention Vaccine Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers
List of Tables and Figures
Figure Product Picture Disease Control and Prevention Vaccine
Figure Market Concentration Ratio and Market Maturity Analysis of Disease Control and Prevention Vaccine
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Disease Control and Prevention Vaccine Market Size by Type
Figure Global Market Share of Disease Control and Prevention Vaccine by Type in 2022
Figure Live-Attenuated Picture
Figure Inactivated Picture
Figure Recombinant Sub Unit and Toxoid Picture
Table Global Disease Control and Prevention Vaccine Market Size (Volume) by Application
Figure Pediatric Vaccine Picture
Figure Adult Vaccine Picture
Table Global Disease Control and Prevention Vaccine Comparison by Regions (M USD) 2018-2028
Figure Global Disease Control and Prevention Vaccine Market Size (Million US$) (2018-2028)
Figure North America Disease Control and Prevention Vaccine Revenue (Million US$) Growth Rate (2018-2028)
Figure Europe Disease Control and Prevention Vaccine Revenue (Million US$) Growth Rate (2018-2028)
Figure Asia-pacific Disease Control and Prevention Vaccine Revenue (Million US$) Growth Rate (2018-2028)
Figure South America Disease Control and Prevention Vaccine Revenue (Million US$) Growth Rate (2018-2028)
Figure Middle East & Africa Disease Control and Prevention Vaccine Revenue (Million US$) Growth Rate (2018-2028)
Table Business Impact Assessment - Covid-19
Table Market Trends and Disease Control and Prevention Vaccine Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Disease Control and Prevention Vaccine Sales by Manufacturer (2018-2023)
Figure Global Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2022
Table Global Disease Control and Prevention Vaccine Revenue by Manufacturer (2018-2023)
Figure Global Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2022
Table Global Disease Control and Prevention Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Disease Control and Prevention Vaccine Manufacturer (Revenue) Market Share in 2022
Figure Top 10 Disease Control and Prevention Vaccine Manufacturer (Revenue) Market Share in 2022
Table Date of Key Manufacturers Enter into Disease Control and Prevention Vaccine Market
Table Key Manufacturers Disease Control and Prevention Vaccine Product Type
Table Mergers & Acquisitions Planning
Table GSK Company Profile
Table Disease Control and Prevention Vaccine Product Introduction, Application and Specification of GSK
Table Disease Control and Prevention Vaccine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of GSK 2018-2023
Table GSK Main Business
Table GSK Recent Development
Table Serum Institute of India Pvt. Ltd Company Profile
Table Disease Control and Prevention Vaccine Product Introduction, Application and Specification of Serum Institute of India Pvt. Ltd
Table Disease Control and Prevention Vaccine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Serum Institute of India Pvt. Ltd 2018-2023
Table Serum Institute of India Pvt. Ltd Main Business
Table Serum Institute of India Pvt. Ltd Recent Development
Table Sanofi Company Profile
Table Disease Control and Prevention Vaccine Product Introduction, Application and Specification of Sanofi
Table Disease Control and Prevention Vaccine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi 2018-2023
Table Sanofi Main Business
Table Sanofi Recent Development
Table Merck & Co., Inc Company Profile
Table Disease Control and Prevention Vaccine Product Introduction, Application and Specification of Merck & Co., Inc
Table Disease Control and Prevention Vaccine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Merck & Co., Inc 2018-2023
Table Merck & Co., Inc Main Business
Table Merck & Co., Inc Recent Development
Table Astellas Pharma Inc Company Profile
Table Disease Control and Prevention Vaccine Product Introduction, Application and Specification of Astellas Pharma Inc
Table Disease Control and Prevention Vaccine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Astellas Pharma Inc 2018-2023
Table Astellas Pharma Inc Main Business
Table Astellas Pharma Inc Recent Development
Table Pfizer Company Profile
Table Disease Control and Prevention Vaccine Product Introduction, Application and Specification of Pfizer
Table Disease Control and Prevention Vaccine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2018-2023
Table Pfizer Main Business
Table Pfizer Recent Development
Table Sinovac Biotech Ltd Company Profile
Table Disease Control and Prevention Vaccine Product Introduction, Application and Specification of Sinovac Biotech Ltd
Table Disease Control and Prevention Vaccine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Sinovac Biotech Ltd 2018-2023
Table Sinovac Biotech Ltd Main Business
Table Sinovac Biotech Ltd Recent Development
Table AstraZeneca PLC Company Profile
Table Disease Control and Prevention Vaccine Product Introduction, Application and Specification of AstraZeneca PLC
Table Disease Control and Prevention Vaccine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of AstraZeneca PLC 2018-2023
Table AstraZeneca PLC Main Business
Table AstraZeneca PLC Recent Development
Table Daiichi Sankyo Company Profile
Table Disease Control and Prevention Vaccine Product Introduction, Application and Specification of Daiichi Sankyo
Table Disease Control and Prevention Vaccine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Daiichi Sankyo 2018-2023
Table Daiichi Sankyo Main Business
Table Daiichi Sankyo Recent Development
Figure Global Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
Figure Global Disease Control and Prevention Vaccine Revenue and Growth Rate (2018-2023)
Table Global Disease Control and Prevention Vaccine Sales by Regions (2018-2023)
Figure Global Disease Control and Prevention Vaccine Sales Market Share by Regions in 2022
Table Global Disease Control and Prevention Vaccine Revenue by Regions (2018-2023)
Figure Global Disease Control and Prevention Vaccine Revenue Market Share by Regions in 2022
Figure North America Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
Figure Europe Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
Figure Asia-pacific Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
Figure South America Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
Figure Middle East & Africa Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
Figure North America Disease Control and Prevention Vaccine Revenue and Growth Rate (2018-2023)
Table North America Disease Control and Prevention Vaccine Sales (Volume) by Countries (2018-2023)
Table North America Disease Control and Prevention Vaccine Sales Market Share by Countries (2018-2023)
Figure North America Disease Control and Prevention Vaccine Sales Market Share by Countries in 2022
Table North America Disease Control and Prevention Vaccine Revenue by Countries (2018-2023)
Table North America Disease Control and Prevention Vaccine Revenue Market Share by Countries (2018-2023)
Figure North America Disease Control and Prevention Vaccine Revenue Market Share by Countries in 2022
Figure United States Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
Figure Canada Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
Figure Mexico Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
Table North America Disease Control and Prevention Vaccine Revenue by Manufacturer (2022)
Figure North America Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2022
Table North America Disease Control and Prevention Vaccine Sales by Type (2018-2023)
Table North America Disease Control and Prevention Vaccine Sales Share by Type (2018-2023)
Table North America Disease Control and Prevention Vaccine Sales by Application (2018-2023)
Table North America Disease Control and Prevention Vaccine Sales Share by Application (2018-2023)
Figure Europe Disease Control and Prevention Vaccine Revenue and Growth Rate (2018-2023)
Table Europe Disease Control and Prevention Vaccine Sales (Volume) by Countries (2018-2023)
Table Europe Disease Control and Prevention Vaccine Sales Market Share by Countries (2018-2023)
Figure Europe Disease Control and Prevention Vaccine Sales Market Share by Countries in 2022
Table Europe Disease Control and Prevention Vaccine Revenue by Countries (2018-2023)
Table Europe Disease Control and Prevention Vaccine Revenue Market Share by Countries (2018-2023)
Figure Europe Disease Control and Prevention Vaccine Revenue Market Share by Countries in 2022
Figure Germany Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
Figure UK Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
Figure France Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
Figure Russia Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
Figure Italy Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
Figure Spain Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
Table Europe Disease Control and Prevention Vaccine Revenue by Manufacturer (2022)
Figure Europe Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2022
Table Europe Disease Control and Prevention Vaccine Sales by Type (2018-2023)
Table Europe Disease Control and Prevention Vaccine Sales Share by Type (2018-2023)
Table Europe Disease Control and Prevention Vaccine Sales by Application (2018-2023)
Table Europe Disease Control and Prevention Vaccine Sales Share by Application (2018-2023)
Figure Asia-pacific Disease Control and Prevention Vaccine Revenue and Growth Rate (2018-2023)
Table Asia-pacific Disease Control and Prevention Vaccine Sales (Volume) by Countries (2018-2023)
Table Asia-pacific Disease Control and Prevention Vaccine Sales Market Share by Countries (2018-2023)
Figure Asia-pacific Disease Control and Prevention Vaccine Sales Market Share by Countries in 2022
Table Asia-pacific Disease Control and Prevention Vaccine Revenue by Countries (2018-2023)
Table Asia-pacific Disease Control and Prevention Vaccine Revenue Market Share by Countries (2018-2023)
Figure Asia-pacific Disease Control and Prevention Vaccine Revenue Market Share by Countries in 2022
Figure China Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
Figure South Korea Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
Figure Japan Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
Figure Australia Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
Figure India Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
Figure Southeast Asia Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
Table Asia-pacific Disease Control and Prevention Vaccine Revenue by Manufacturer (2022)
Figure Asia-pacific Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2022
Table Asia-pacific Disease Control and Prevention Vaccine Sales by Type (2018-2023)
Table Asia-pacific Disease Control and Prevention Vaccine Sales Share by Type (2018-2023)
Table Asia-pacific Disease Control and Prevention Vaccine Sales by Application (2018-2023)
Table Asia-pacific Disease Control and Prevention Vaccine Sales Share by Application (2018-2023)
Figure South America Disease Control and Prevention Vaccine Revenue and Growth Rate (2018-2023)
Table South America Disease Control and Prevention Vaccine Sales (Volume) by Countries (2018-2023)
Table South America Disease Control and Prevention Vaccine Sales Market Share by Countries (2018-2023)
Figure South America Disease Control and Prevention Vaccine Sales Market Share by Countries in 2020
Table South America Disease Control and Prevention Vaccine Revenue by Countries (2018-2023)
Table South America Disease Control and Prevention Vaccine Revenue Market Share by Countries (2018-2023)
Figure South America Disease Control and Prevention Vaccine Revenue Market Share by Countries in 2020
Figure Brazil Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
Table South America Disease Control and Prevention Vaccine Sales by Type (2018-2023)
Table South America Disease Control and Prevention Vaccine Sales Share by Type (2018-2023)
Table South America Disease Control and Prevention Vaccine Revenue by Type (2018-2023)
Table South America Disease Control and Prevention Vaccine Revenue Share by Type (2018-2023)
Table South America Disease Control and Prevention Vaccine Sales by Application (2018-2023)
Table South America Disease Control and Prevention Vaccine Sales Share by Application (2018-2023)
Figure Middle East and Africa Disease Control and Prevention Vaccine Revenue and Growth Rate (2018-2023)
Table Middle East and Africa Disease Control and Prevention Vaccine Sales (Volume) by Countries (2018-2023)
Table Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share by Countries (2018-2023)
Figure Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share by Countries in 2020
Table Middle East and Africa Disease Control and Prevention Vaccine Revenue by Countries (2018-2023)
Table Middle East and Africa Disease Control and Prevention Vaccine Revenue Market Share by Countries (2018-2023)
Figure Middle East and Africa Disease Control and Prevention Vaccine Revenue Market Share by Countries in 2020
Figure GCC Countries Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
Figure Turkey Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
Figure Egypt Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
Figure South Africa Disease Control and Prevention Vaccine Sales and Growth Rate (2018-2023)
Table Middle East and Africa Disease Control and Prevention Vaccine Sales by Type (2018-2023)
Table Middle East and Africa Disease Control and Prevention Vaccine Sales Share by Type (2018-2023)
Table Middle East and Africa Disease Control and Prevention Vaccine Revenue by Type (2018-2023)
Table Middle East and Africa Disease Control and Prevention Vaccine Revenue Share by Type (2018-2023)
Table Middle East and Africa Disease Control and Prevention Vaccine Sales by Application (2018-2023)
Table Middle East and Africa Disease Control and Prevention Vaccine Sales Share by Application (2018-2023)
Table Global Disease Control and Prevention Vaccine Sales by Type (2018-2023)
Table Global Disease Control and Prevention Vaccine Sales Market Share by Type (2018-2023)
Figure Global Disease Control and Prevention Vaccine Sales Market Share by Type in 2022
Table Global Disease Control and Prevention Vaccine Revenue by Type (2018-2023)
Table Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2018-2023)
Figure Global Disease Control and Prevention Vaccine Revenue Market Share by Type in 2020
Figure Global Live-Attenuated Sales Growth Rate (2018-2023)
Figure Global Live-Attenuated Price (2018-2023)
Figure Global Inactivated Sales Growth Rate (2018-2023)
Figure Global Inactivated Price (2018-2023)
Figure Global Recombinant Sub Unit and Toxoid Sales Growth Rate (2018-2023)
Figure Global Recombinant Sub Unit and Toxoid Price (2018-2023)
Table Global Disease Control and Prevention Vaccine Sales by Application (2018-2023)
Table Global Disease Control and Prevention Vaccine Sales Market Share by Application (2018-2023)
Figure Global Disease Control
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|